LVW Advisors LLC Acquires Shares of 1,955 Oracle Co. (NYSE:ORCL)

LVW Advisors LLC bought a new stake in shares of Oracle Co. (NYSE:ORCL) in the first quarter, HoldingsChannel.com reports. The institutional investor bought 1,955 shares of the enterprise software provider’s stock, valued at approximately $246,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Roberts Wealth Advisors LLC grew its stake in shares of Oracle by 1.7% in the first quarter. Roberts Wealth Advisors LLC now owns 14,501 shares of the enterprise software provider’s stock worth $1,738,000 after acquiring an additional 247 shares during the last quarter. Financial Partners Group LLC purchased a new stake in shares of Oracle in the first quarter worth $248,000. Clarity Wealth Advisors LLC grew its stake in shares of Oracle by 3.2% in the first quarter. Clarity Wealth Advisors LLC now owns 4,165 shares of the enterprise software provider’s stock worth $523,000 after acquiring an additional 130 shares during the last quarter. Chatham Capital Group Inc. grew its stake in shares of Oracle by 6.0% in the first quarter. Chatham Capital Group Inc. now owns 32,709 shares of the enterprise software provider’s stock worth $4,109,000 after acquiring an additional 1,866 shares during the last quarter. Finally, Strata Wealth Advisors LLC purchased a new stake in shares of Oracle in the first quarter worth $202,000. Institutional investors own 42.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. BMO Capital Markets increased their price objective on Oracle from $142.00 to $160.00 and gave the company a “market perform” rating in a research report on Monday, June 17th. JMP Securities reaffirmed a “market perform” rating on shares of Oracle in a research report on Tuesday, June 11th. Sanford C. Bernstein increased their price objective on Oracle from $159.00 to $171.00 and gave the company an “outperform” rating in a research report on Wednesday, June 12th. Citigroup dropped their price objective on Oracle from $133.00 to $128.00 and set a “neutral” rating on the stock in a research report on Monday, June 10th. Finally, Oppenheimer initiated coverage on Oracle in a research report on Thursday, April 18th. They set a “market perform” rating on the stock. Fourteen investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $145.83.

Insider Buying and Selling

In other Oracle news, insider Edward Screven sold 37,221 shares of the stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $140.19, for a total transaction of $5,218,011.99. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $368,246,045.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Edward Screven sold 37,221 shares of the stock in a transaction that occurred on Wednesday, June 26th. The stock was sold at an average price of $140.19, for a total value of $5,218,011.99. Following the completion of the sale, the insider now owns 2,626,764 shares of the company’s stock, valued at $368,246,045.16. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director George H. Conrades sold 20,000 shares of the stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the completion of the sale, the director now directly owns 17,836 shares of the company’s stock, valued at approximately $2,068,976. The disclosure for this sale can be found here. In the last 90 days, insiders sold 385,639 shares of company stock valued at $53,002,729. 42.80% of the stock is owned by company insiders.

Oracle Stock Up 0.7 %

Shares of ORCL stock opened at $141.20 on Monday. Oracle Co. has a 1-year low of $99.26 and a 1-year high of $145.32. The stock’s fifty day moving average price is $125.24 and its 200 day moving average price is $118.19. The company has a debt-to-equity ratio of 8.25, a current ratio of 0.71 and a quick ratio of 0.72. The company has a market cap of $389.13 billion, a price-to-earnings ratio of 38.06, a price-to-earnings-growth ratio of 2.56 and a beta of 1.02.

Oracle (NYSE:ORCL) last posted its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share for the quarter, missing the consensus estimate of $1.65 by ($0.02). The firm had revenue of $14.29 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Oracle had a net margin of 19.76% and a return on equity of 223.01%. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.35 EPS. On average, research analysts expect that Oracle Co. will post 5.01 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 25th. Investors of record on Thursday, July 11th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Thursday, July 11th. This represents a $1.60 dividend on an annualized basis and a yield of 1.13%. Oracle’s payout ratio is 43.13%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.